PRONESTYL Drug Patent Profile
✉ Email this page to a colleague
When do Pronestyl patents expire, and when can generic versions of Pronestyl launch?
Pronestyl is a drug marketed by Apothecon and is included in three NDAs.
The generic ingredient in PRONESTYL is procainamide hydrochloride. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the procainamide hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pronestyl
A generic version of PRONESTYL was approved as procainamide hydrochloride by INTL MEDICATION on July 31st, 1984.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PRONESTYL?
- What are the global sales for PRONESTYL?
- What is Average Wholesale Price for PRONESTYL?
Summary for PRONESTYL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 72 |
| Clinical Trials: | 2 |
| Patent Applications: | 4,060 |
| DailyMed Link: | PRONESTYL at DailyMed |
Recent Clinical Trials for PRONESTYL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Jeffrey Moak | Phase 4 |
| Medtronic | Phase 3 |
| Mayo Clinic | Phase 3 |
US Patents and Regulatory Information for PRONESTYL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apothecon | PRONESTYL | procainamide hydrochloride | CAPSULE;ORAL | 007335-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apothecon | PRONESTYL | procainamide hydrochloride | TABLET;ORAL | 017371-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apothecon | PRONESTYL | procainamide hydrochloride | INJECTABLE;INJECTION | 007335-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apothecon | PRONESTYL | procainamide hydrochloride | TABLET;ORAL | 017371-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apothecon | PRONESTYL | procainamide hydrochloride | CAPSULE;ORAL | 007335-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apothecon | PRONESTYL | procainamide hydrochloride | CAPSULE;ORAL | 007335-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
